Mechanisms and therapeutic advances of gut metabolites in the regulation of neuroimmune inflammatory diseases - Scorecard - MDSpire

Mechanisms and therapeutic advances of gut metabolites in the regulation of neuroimmune inflammatory diseases

  • By

  • Xiaodan Shen

  • Caiji Zheng

  • Renyong Lin

  • Juan Wang

  • Zheng Chen

  • June 2, 2026

  • 0 min

Share

Clinical Scorecard: Advancements in Understanding Gut Metabolites and Their Role in Neuroimmune Inflammatory Disease Regulation

At a Glance

CategoryDetail
ConditionNeuroimmune inflammatory diseases
Key MechanismsGut-derived metabolites, such as short-chain fatty acids (SCFAs) and bile acids, modulate immune responses and influence central nervous system (CNS) functions.
Target PopulationIndividuals with neuroimmune inflammatory disorders, including multiple sclerosis (MS), Alzheimer’s disease (AD), and neuromyelitis optica spectrum disorders (NMOSD).
Care SettingClinical and research settings focusing on neuroimmunology and gut microbiota.

Key Highlights

  • SCFAs promote regulatory T-cell differentiation and exert neuroprotective effects.
  • Bile acids have a dual role, with some promoting anti-inflammatory responses and others inducing neuroinflammation.
  • Dysbiosis of gut microbiota is linked to neuroimmune inflammatory diseases.
  • Therapeutic strategies target the gut-immune-brain axis through immune modulation and microbiota restoration.
  • Future research aims to clarify molecular interactions between metabolites and immune cells.

Guideline-Based Recommendations

Diagnosis

  • Assess metabolite profiles and gut microbiota composition in patients with neuroimmune inflammatory diseases.

Management

  • Consider interventions that modulate gut microbiota and metabolites to influence neuroimmune pathways.

Monitoring & Follow-up

  • Regularly evaluate the inflammatory markers and metabolite levels in patients undergoing treatment.

Risks

  • Monitor for potential neurotoxic effects of certain bile acids in the context of gut dysbiosis.

Patient & Prescribing Data

Patients with neuroimmune inflammatory diseases characterized by altered gut microbiota and metabolite profiles.

Probiotics, prebiotics, and metabolite supplements may help restore gut balance and mitigate neuroinflammation.

Clinical Best Practices

  • Incorporate dietary and microbiota-focused strategies in the management of neuroimmune inflammatory diseases.
  • Utilize a multidisciplinary approach involving neurologists, immunologists, and nutritionists.

Related Resources & Content

Original Source(s)

Related Content